PI3Kα Pathway Inhibition With Doxorubicin Treatment Results in Distinct Biventricular Atrophy and Remodeling With

Brent A McLean1,2, Vaibhav B Patel2,3, Pavel Zhabyeyev2,3

  • 11 Department of Physiology University of Alberta Edmonton Canada.

Insights

Cancer therapies targeting PI 3Kα (phosphoinositide 3-kinase-α) can harm the heart. This study found PI 3Kα inhibition combined with chemotherapy specifically risks right ventricular dilation and dysfunction.

Area of Science:

  • Cardiology
  • Oncology
  • Molecular Biology

Background:

  • Cancer therapies targeting PI 3Kα (phosphoinositide 3-kinase-α) signaling can cause cardiac adverse effects.
  • The impact of PI 3Kα pathway inhibition on heart health during cancer treatment remains unclear.

Purpose of the Study:

  • To investigate the effects of PI 3Kα pathway inhibition on heart atrophy, remodeling, and function.
  • To determine the specific cardiac risks associated with combined PI 3Kα inhibition and chemotherapy.

Main Methods:

  • Utilized pharmacological PI 3Kα inhibition and genetic deletion of p110α in murine models.
  • Administered anthracycline (doxorubicin) chemotherapy concurrently.
  • Analyzed biventricular morphology, function, and molecular signaling pathways.

Main Results:

  • Both PI 3Kα inhibition and doxorubicin promoted heart atrophy.
  • Combined therapy led to right ventricular dilation, dysfunction, and cardiomyocyte remodeling without pulmonary hypertension.
  • Increased p38 mitogen-activated protein kinase activation was linked to heart atrophy and right ventricular dysfunction.

Conclusions:

  • PI 3Kα pathway inhibition contributes to heart atrophy.
  • The right ventricle is particularly vulnerable to dilation and dysfunction when PI 3Kα inhibition is combined with chemotherapy.
  • Inhibiting p38 mitogen-activated protein kinase may mitigate this cardiotoxicity.

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.0K
Nucleosome Remodeling02:54

Nucleosome Remodeling

Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
10.8K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.3K
C4 Pathway and CAM01:27

C4 Pathway and CAM

Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
48.9K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.0K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.8K